Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
Protillion Biosciences Inc. has 2 pending office actions in Biotechnology & Pharmaceuticals. The matters are assigned to 2 examiners and 2 art units, giving each file a separate examination setting.
PLAYER, ROBERT AUSTIN is the busiest examiner, with 1 pending matter. Counsel can handle the files independently while checking that biotechnology terminology and supporting disclosure remain consistent.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| PLAYER, ROBERT AUSTIN | 1 | 13.6% | +34.1% |
| BUCHANAN, BAILEY CHEYENNE | 1 | 42.9% | +57.1% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19552708 | METHODS, SYSTEMS, AND COMPOSITIONS OF GENERATING AND ANALYZING POLYPEPTIDE LIBRARIES | PLAYER, ROBERT AUSTIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19552708 | METHODS, SYSTEMS, AND COMPOSITIONS OF GENERATING AND ANALYZING POLYPEPTIDE LIBRARIES | PLAYER, ROBERT AUSTIN | — |
| 18007032 | SYSTEMS AND METHODS FOR ASSAYING A PLURALITY OF POLYPEPTIDES | BUCHANAN, BAILEY CHEYENNE | — |
| Art Unit | Apps |
|---|---|
| 1686 | 1 |
| 1682 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19552708 | METHODS, SYSTEMS, AND COMPOSITIONS OF GENERATING AND ANALYZING POLYPEPTIDE LIBRARIES | PLAYER, ROBERT AUSTIN | 1686 | §103§112Other | Final Rejection | — | Pending | Feb 27, 2026 |
| 18007032 | SYSTEMS AND METHODS FOR ASSAYING A PLURALITY OF POLYPEPTIDES | BUCHANAN, BAILEY CHEYENNE | 1682 | §103 | Final Rejection | — | Pending | Jan 26, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialProtillion Biosciences Inc. has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Robert Austin Player has the most, with 1 of Protillion Biosciences Inc.'s pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.